Obstetrics and Gynecology
doi: 10.25005/2074-0581-2023-25-2-235-247
MODERN CONCEPTS OF VOMITING OF PREGNANCY

G.Kh. Kurbanova

Department of Obstetrics and Gynecology № 1, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan

Objective: This review discusses some aspects of the most common complication of the early gestational period – toxicosis. Vomiting of pregnant women (VP) is one of the frequent manifestations of early toxicosis. This disorder affects the quality of life of a pregnant woman, causes exhaustion, and contributes to the disruption of homeostasis, weakness, and dysfunction of various organs and systems. In addition, it may lead to miscarriage, placental insufficiency, insufficient weight gain during gestation, various perinatal pathologies in children, and other complications. Therefore, VP despite numerous studies conducted throughout the world, remains one of the urgent problems of obstetrics, the solution of which requires sufficient evidence-based research. Papers on various aspects of VP from the PubMed and Google Scholar electronic databases were analyzed. More than 500 sources were found, of which 50 were selected and included in the review, based on the selected keywords.

Keywords: Pregnancy, changes in the body of a pregnant woman, pregnancy complications, pregnancy toxicosis, vomiting and nausea in pregnant women, perinatal outcomes.

Download file:

References
  1. Dodkhoeva MF, Uzakova UD, Ismailova TD, Kodirova SG, Barieva LS, i dr. Patologiya beremennosti (metodicheskie rekomendatsii dlya razrabotki klinicheskikh protokolov v rodospomogatel'nykh uchrezhdeniyakh) [Pathology of pregnancy (guidelines for the development of clinical protocols in obstetric institutions)]. Moscow, RF: GEOTAR-Media; 2015. pp. 10-80.
  2. Dodkhoeva MF, Uzakova UD, Ismailova TD, Kodirova SG, Barieva LS, i dr. Patologiya beremennosti (metodicheskie rekomendatsii dlya razrabotki klinicheskikh protokolov v rodospomogatel'nykh uchrezhdeniyakh) [Pathology of pregnancy (guidelines for the development of clinical protocols in obstetric institutions)]. Moscow, RF: GEOTAR-Media; 2015. pp. 10-80.
  3. Skuladottir H, Wilcox AJ, Ma C, Lammer EJ, Rasmussen SA, Werler MM, et al. Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2014;100(6):499-506. https://doi.org/10.1002/bdra.23248
  4. Fejzo MS, Trovik J, Grooten IJ, Sridharan K, Roseboom TJ, Vikanes Å, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers. 2019;5(1):62. https://doi.org/10.1038/s41572-019-0110-3
  5. Strizhakov AN, Tezikov YuV, Lipatov IS, Sharypova MA, Anpilogova IV, Azizov KU, i dr. Standartizatsiya diagnostiki i klinicheskaya klassifikatsiya khronicheskoy platsentarnoy nedostatochnosti [Standardization of diagnostics and clinical classification of chronic placental insufficiency]. Voprosy ginekologii, akusherstva i perinatologii. 2014;13(3):5-12.
  6. Shehmar M, Maclean MA, Nelson-Piercy C, Gadsby R, O’Hara M. The management of nausea and vomiting of pregnancy and hyperemesis gravidarum Green-top Guideline No. 69. Royal College of Obstetricians and Gynaecologists; 2016. Available at: https://www.rcog.org.uk/globalassets/ documents/guidelines/green-top-guidelines/gtg69-hyperemesis.pdf.
  7. Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: A meta-analysis. J Popul Ther Clin Pharmacol. 2013;20(2):e171-83.
  8. Fiaschi L, Nelson-Piercy C, Gibson J, Szatkowski L, Tata LJ. Adverse maternal and birth outcomes in women admitted to hospital for hyperemesis gravidarum: A population-based cohort study. Paediatr Perinat Epidemiol. 2018;32(1):40-51. https://doi.org/10.1111/ppe.12416
  9. Dean CR, Bruin CM, O’Hara ME, Roseboom TJ, Leeflang MM, Spijker R, et al. The chance of recurrence of hyperemesis gravidarum: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2020;5:100105. https://doi.org/10.1016/j. eurox.2019.100105
  10. Nana M, Tydeman F, Bevan G, Boulding H, Kavanagh K, Dean C, et al. Hyperemesis gravidarum is associated with increased rates of termination of pregnancy and suicidal ideation: Results from a survey completed by >5000 participants. Am J Obstet Gynecol. 2021;224(6):629-31. https://doi.org/10.1016/j. ajog.2021.03.006
  11. Eliakim R, Abulafia O, Sherer DM. Hyperemesis gravidarum: A current review. Am J Perinatol. 2000;17(4):207-18. https://doi.org/10.1055/s-2000-9424
  12. Nijsten K, Dean C, van der Minnen LM, Bais JMJ, Ris-Stalpers C, van Eekelen R, et al. Recurrence, postponing pregnancy, and termination rates after hyperemesis gravidarum: Follow up of the MOTHER study. Acta Obstet Gynecol Scand. 2021;100(9):1636-43. https://doi.org/10.1111/aogs.14197
  13. Veenendaal MV, van Abeelen AF, Painter RC, van der Post JA, Roseboom TJ. Consequences of hyperemesis gravidarum for offspring: A systematic review and meta-analysis. BJOG. 2011;118(11):1302-13. https://doi.org/10.1111/ j.1471-0528.2011.03023.x
  14. Pirimoglu ZM, Guzelmeric K, Alpay B, Balcik O, Unal O, Turan MC. Psychological factors of hyperemesis gravidarum by using the SCL-90-R questionnaire. Clin Exp Obstet Gynecol. 2010;37(1):56-9.
  15. Ahn J, Reau NS. ACG Clinical Guideline: Liver Disease and Pregnancy. Am J Gastroenterol. 2016;111(2):176-94.https://doi.org/10.1038/ajg.2015.430
  16. Savelieva GM, Sukhikh GT, Serova VN, Radzinskiy VE (red.). Akusherstvo: national'noe rukovodstvo. 2-e izd.[Obstetrics: A national guide. 2nd ed.]. Moscow, RF: GEOTAR-Media; 2018.1088 p.
  17. Borisova MA, Moiseenko DYu, Smirnova OV. Khorionicheskiy gonadotropin cheloveka: neizvestnoe ob izvestnom [Human chorionic gonadotropin: The unknown about the known]. Fiziologiya cheloveka. 2017;1:97-110. https://doi. org/10.7868/S0131164616060059
  18. Martirosyan MS, Reut VA. Fiziologicheskie izmeneniya v organizme beremennoy zhenshchiny [Physiological changes in the body of a pregnant woman]. Voprosy ustoychivogo razvitiya obshchestva. 2020;1:454-63. https://doi. org/10.34755/IROK.2020.52.24.208
  19. Bustos M, Venkataramanan R, Caritis S. Nausea and vomiting of pregnancy – what's new? Auton Neurosci. 2017;202:62-72. https://doi.org/10.1016/j.autneu.2016.05.002
  20. Lipatov IS, Tezikov YuV, Kutuzova OA, Prikhodko AV, Frolova NA, Ryabova SA. Kliniko-patogeneticheskie varianty dezadaptatsii beremennykh na rannikh srokakh gestatsii [Clinical and pathogenetic variants of maladaptation of pregnant women in the early stages of gestation]. Akusherstvo, ginekologiya i reproduktsiya. 2017;1:5-13. https://doi.org/10.17749/2313-7347.2017.11.1.005-013
  21. Jahani F, Khazaei Z, Moodi M, Zarban A, Salmani F, Tahergorabi Z. The relation of visfatin with nausea and vomiting in the pregnancy. J Res Med Sci. 2020;25:80. https://doi.org/10.4103/jrms.jrms_39_20
  22. Niebyl JR. Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med. 2010;363(16):1544-50. https://doi.org/10.1056/ NEJMcp1003896
  23. Shaban MM, Kandil HO, Elshafei AH. Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. Am J Med Sci. 2014;347(2):101-5. https:// doi.org/10.1097/ MAJ.0b013e31827bef91
  24. Arshad MF, Javed N, Bekhit M. Intractable hyperemesis gravidarum in a patient with type 1 diabetes. BMJ Case Rep. 2017;2017:bcr2017222403. https://doi. org/10.1136/bcr-2017-222403
  25. Mravyan SR, Petrukhin VA. «Terapevticheskiy nigilizm», patogenez i iskhody rvoty beremennykh ["Therapeutic nihilism", pathogenesis and outcomes of vomiting of pregnant women]. RMZH. 2016;15:966-70.
  26. Bacak SJ, Thornburg LL. Liver failure in pregnancy. Crit Care Clin. 2016;32(1):61- 72. https://doi.org/10.1016/j. ccc.2015.08.005
  27. Gusak YuK, Chikin VG, Khovanov AV, Novikova AV, Gusak NYu. Antenatal'naya gibel' ploda: kliniko-biokhimicheskie paralleli i osobennosti rodorazresheniya [Antenatal fetal death: Clinical and biochemical parallels and features of delivery]. Glavnyy vrach Yuga Rossii. 2020;5:18-23.
  28. Zhang H, Wu S, Feng J, Liu Z. Risk factors of prolonged nausea and vomiting during pregnancy. Risk Manag Healthc Policy. 2020;13:2645-54. https://doi. org/10.2147/RMHP.S273791
  29. Keskinkılıç B, Uygur D, Ozcan A, Üstün Y, Keskin H, Karaahmetoğlu S, et al. Pulmonary embolism associated with hyperemesis gravidarum two case reports. Gynecol Obstet Reprod Med. 2016;23(3):169-70. https://doi.org/10.21613/ GORM.2016.490
  30. Grooten IJ, Mol BW, van der Post JAM, Ris-Stalpers C, Kok M, Bais JMJ, et al. Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: The MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding). BMC Pregnancy Childbirth. 2016;16:22. https://doi.org/10.1186/s12884-016-0815-1
  31. Bischoff SC, Renzer C. Nausea and nutrition. Auton Neurosci. 2006;129(1-2):22- 7. https://doi.org/10.1016/j.autneu.2006.07.011
  32. Blbulyan AK, Abraamyan RA, Aslanyan OA, Torosyan LM, Blbulyan TA. Plazmaferez – al'ternativnyy metod korrektsii hyperemesis gravidarum [Plasmapheresis is an alternative method of correction of hyperemesis gravidarum]. Vestnik Rossiyskogo universiteta druzhby narodov. Seriya: Meditsina. 2011;6:79-84.
  33. Marinkin IO, Sokolova TM, Kiselyova TV, Kuleshov VM, Makarov KYu, Yakimova AV, i dr. Rvota beremennykh [Vomiting of pregnant women]. Eksperimental'naya i klinicheskaya gastroenterologiya. 2018;7:142-5.
  34. Amzajerdi A, Keshavarz M, Montazeri A, Bekhradi R. Effect of mint aroma on nausea, vomiting and anxiety in pregnant women. J Family Med Prim Care. 2019;8(8):2597-601. https://doi.org/10.4103/jfmpc.jfmpc_480_19
  35. Mozheyko LF, Poukh MA. Primenenie kompleksnogo preparata Preginor v lechenii rvoty beremennykh [The use of the complex drug Preginor in the treatment of vomiting of pregnant women]. Reproduktivnoe zdorov'e. Vostochnaya Evropa. 2020;5:638-46. https://doi.org/10.34883/PI.2020.10.5.013
  36. Strizhakov AN, Ignatko IV. Rannie sroki beremennosti: oslozhneniya i prognozirovanie perinatal'nyh iskhodov [Early pregnancy: Complications and prognosis of perinatal outcomes]. Voprosy ginekologii, akusherstva i perinatologii. 2012;5:5-12.
  37. Haniadka R, Saldanha E, Sunita V, Palatty PL, Fayad R, Baliga MS. A review of the gastroprotective effects of ginger (Zingiberofficinale Roscoe). Food Funct. 2013;4(6):845-55. https://doi.org/10.1039/c3fo30337c
  38. Stanisiere J, Mousset PY, Lafay S. How safe is ginger rhizome for decreasing nausea and vomiting in women during early pregnancy? Foods. 2018;7(4):50. https://doi.org/10.3390/foods7040050
  39. Gilboa SM, Ailes EC, Rai RP, Anderson JA, Honein MA. Antihistamines and birth defects: A systematic review of the literature. Expert Opin Drug Saf. 2014;13(12):1667-98. https://doi.org/10.1517/14740338. 2014.970164
  40. Tan PC, Khine PP, Vallikkannu N, Omar SZ. Promethazine compared with metoclopramide for hyperemesis gravidarum: A randomized controlled trial. Obstet Gynecol. 2010;115(5):975-81. https://doi.org/10.1097/ AOG.0b013e3181d99290
  41. Carstairs SD. Ondansetron use in pregnancy and birth defects: A systematic review. Obstet Gynecol. 2016;127(5):878-83. https://doi.org/10.1097/ AOG.0000000000001388
  42. Danielsson B, Wikner BN, Källén B. Use of ondansetron during pregnancy and congenital malformations in the infant. Reprod Toxicol. 2014;50:134-7. https:// doi.org/10.1016/j.reprotox.2014.10.017
  43. Gill SK, Maltepe C, Koren G. The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy. Can J Gastroenterol. 2009;23(4):270- 2. https://doi.org/10.1155/2009/678514
  44. Sanu O, Lamont RF. Hyperemesis gravidarum: Pathogenesis and the use of antiemetic agents. Expert Opin Pharmacother. 2011;12(5):737-48. . https://doi.or g/10.1517/14656566.2010.537655
  45. Pasternak B, Svanström H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 2013;368(9):814-23. https://doi. org/10.1056/NEJMoa1211035
  46. Zielinski R, Searing K, Deibel M. Gastrointestinal distress in pregnancy: Prevalence, assessment, and treatment of 5 common minor discomforts. J Perinat Neonatal Nurs. 2015;29(1):23-31. https://doi.org/10.1097/ JPN.0000000000000078
  47. Pradat P, Robert-Gnansia E, Di Tanna GL, Rosano A, Lisi A, Mastroiacovo P; Contributors to the MADRE database. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol. 2003;67(12):968-70. https://doi.org/10.1002/ bdra.10134
  48. Kontonika SM, Grammatikopoulou MG, Theodoridis X, Tsirou E, Gkiouras K, Tirodimos I, et al. Evaluation of diet quality and hyperemesis gravidarum in pregnant women according to income. Clin Nutr ESPEN. 2018;24:174-5. https://doi.org/10.1016/j.clnesp.2018.01.015
  49. Parker SE, Starr JR, Collett BR, Speltz ML, Werler MM. Nausea and vomiting during pregnancy and neurodevelopmental outcomes in offspring. Paediatr Perinat Epidemiol. 2014;28(6):527-35. https://doi.org/10.1111/ppe.12151
  50. Baltaniyazova GP, Rasul-Zade YuG. Toshnota i rvota beremennykh: novye aspekty diagnostiki i lecheniya [Nausea and vomiting of pregnant women: New aspects of diagnosis and treatment]. Doktor akhborotnomasi. 2020;4:150-4. https://doi.org/10.38095/2181-466X-2020974-150-154

Authors' information:

Kurbanova Gulandom Khaydarshoevna,
PhD Student of the Department of Obstetrics and Gynecology № 1, Avicenna Tajik State Medical University
ORCID ID: 0000-0002-4979-7896
E-mail: gulandom210892@mail.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:

Kurbanova Gulandom Khaydarshoevna
PhD Student of the Department of Obstetrics and Gynecology № 1, Avicenna Tajik State Medical University

734003, Republic of Tajikistan, Dushanbe, Rudaki Ave., 139

Tel.: +992 (886) 382828

E-mail: gulandom210892@mail.ru

Materials on the topic:
  1. RISK FACTORS FOR SPONTANEOUS PRETERM BIRTH
  2. PREMATURE SEPARATION OF THE NORMALLY IMPLANTED PLACENTA
  3. MORPHOFUNCTIONAL FEATURES OF THE PLACENTA IN PREGNANT WOMEN WITH TUBERCULOSIS
  4. INDUCTION OF LABOR IN PRE-ECLAMPTIC WOMEN
  5. EMERGENCY CESAREAN SECTION WITH REDO MITRAL VALVE REPLACEMENT FOR ACUTE PROSTHETIC VALVE DYSFUNCTION: A CASE REPORT
  6. EPIDEMIOLOGY AND RISK FACTORS FOR MATERNAL SEPSIS
  7. FOLATE METABOLISM IN PREGNANCY
  8. Reserves for improving perinatal indicators by analyzing the outcomes of preterm labor
  9. ASSESSMENT OF THE UFS-QOL QUESTIONNAIRE BEFORE AND AFTER UTERINE ARTERY EMBOLIZATION FOR UTERINE LEIOMYOMA
  10. CHARACTERISTICS OF SOME OBSTETRIC AND GYNECOLOGICAL FEATURES IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME AND CONCOMITANT THYROID GLAND PATHOLOGY

◄ Back to the list